Edition:
United Kingdom

ADMA Biologics Inc (ADMA.OQ)

ADMA.OQ on NASDAQ Stock Exchange Capital Market

4.24USD
5:25pm BST
Change (% chg)

$0.05 (+1.32%)
Prev Close
$4.18
Open
$4.25
Day's High
$4.34
Day's Low
$4.22
Volume
108,827
Avg. Vol
193,185
52-wk High
$6.96
52-wk Low
$2.08

About

ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments... (more)

Overall

Beta: 2.10
Market Cap(Mil.): $82.28
Shares Outstanding(Mil.): 25.79
Dividend: --
Yield (%): --

Financials

  ADMA.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.75 -- --
ROI: -51.15 8.91 13.82
ROE: -154.84 10.05 15.24

UPDATE 1-FDA declines to approve re-launch of ADMA Biologics' Bivigam

Dec 19 The U.S. Food and Drug Administration (FDA)on Wednesday declined to approve ADMA Biologics Inc's application to re-launch its immune deficiency treatment Bivigam, the company said.

19 Dec 2018

FDA declines to approve re-launch of ADMA Biologics' Bivigam

Dec 19 The U.S. Food and Drug Administration on Wednesday declined to approve ADMA Biologics Inc's application to re-launch its immune deficiency treatment Bivigam, the company said.

19 Dec 2018

Earnings vs. Estimates